language_icon
EN
HI

Sandu Pharmaceuticals Share price

SANDUPHQ

39.5

1.00 (2.60%)
Last updated on 12 Dec, 2025 | 15:26 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

40.99

Today's Low

38.18

52 Week Low

36.76

52 Week High

62.80

alert_iconThe current prices are delayed, login to your account for live prices

Sandu Pharmaceuticals Chart

Sandu Pharmaceuticals Share Key Metrics

Volume
2144.00
Market Cap
37.19 CR
LTQ@LTP
9@39.50
ATP
39.45
Var Margin
25 %
Circuit Range
30.8-46.2
Delivery %
0 %
Value
84580.80
ASM/GSM
No
Market Lot
1

Summary

At 12 Dec, 2025 | 15:26, Sandu Pharmaceuticals share price stands at ₹39.5, showing a 1.00% 2.60 for the day. The stock’s intraday movement has stayed between ₹38.18 and ₹40.99, while on a 52-week basis it has fluctuated from ₹36.76 to ₹62.80.
In terms of trading activity, Sandu Pharmaceuticals has recorded a volume of 2144 shares, with a market capitalisation of ₹9660990. The stock’s Average Traded Price (ATP) stands at ₹3945, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9,3950. The stock operates within a circuit range of ₹30.8-46.2, with a Value of ₹84580.80. The Delivery Percentage for the day is %. Additionally, Sandu Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

Sandu Pharmaceuticals Fundamentals

View More
P/E Ratio

23.78

P/B Ratio

1.1

Div. Yield

2.09

Sector P/E

36.23

Sector P/B

1.22

Sec. Div. Yield

0.57

Sandu Pharmaceuticals Resistance and Support

Pivot 50.14

Resistance

First Resistance

50.53

Second Resistance

51.11

Third Resistance

51.5

Support

First Support

49.56

Second Support

49.17

Third Support

48.59

Sandu Pharmaceuticals Futures & Options

Data Not Found

Sandu Pharmaceuticals Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

42.91%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0.01%

Retail

57.08%

Others

0%

Total Promoters
MAR '25
42.9%
JUN '25
42.9%
SEP '25
42.91%

Sandu Pharmaceuticals Corporate Actions

DateAgenda
2025-11-12Quarterly Results
2025-10-14Others
2025-08-13Quarterly Results
2025-05-28Audited Results & Final Dividend
2025-02-13Quarterly Results
2024-11-14Quarterly Results
2024-08-12Quarterly Results & Final Dividend

Sandu Pharmaceuticals News

NSE-BSE bulk deals: Porinju Veliyath sells stake in Sandu Pharmaceuticals

Jul 09 2021 22:46:00

NSE-BSE bulk deals: Porinju Veliyath sells stake in Sandu Pharmaceuticals

Jul 09 2021 22:35:56
Read More

About Sandu Pharmaceuticals

NSE : 0  
BSE : 524703  
ISIN : INE751D01014  

Sandu Pharmaceuticals Management

NamePosition
Mr. Umesh B Sandu Executive Director
Mr. Shashank B Sandu Non Exe.Non Ind.Director
View More

Sandu Pharmaceuticals FAQs

The Buying Price of Sandu Pharmaceuticals share is 39.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Sandu Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sandu Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Sandu Pharmaceuticals shares is 23.78. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Sandu Pharmaceuticals shares is 1.1. Useful to assess the stock's value relative to its book value.

To assess Sandu Pharmaceuticals’s valuation compare Sector P/E, P/B which are 36.23 & 1.22 with sector averages, along with growth rates and financial metrics.

The Market Cap of Sandu Pharmaceuticals is 37.19 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Sandu Pharmaceuticals share price is 62.80 & 36.76. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Sandu Pharmaceuticals belongs to the Healthcare sector.